Literature DB >> 19079271

Endocrine manifestations of hepatitis C virus infection.

Alessandro Antonelli1, Clodoveo Ferri, Silvia Martina Ferrari, Michele Colaci, Domenico Sansonno, Poupak Fallahi.   

Abstract

Chronic infection with hepatitis C virus (HCV) can result in both hepatic and extrahepatic disease and endocrine dysfunction represents an important class of HCV-related extrahepatic disease. The most frequently occurring--and clinically important--of these endocrine disorders are thyroid disease and type 2 diabetes mellitus. In this Review, we evaluate the evidence in support of a link between HCV infection and endocrine-system dysfunction, and discuss potential pathophysiological mechanisms. A meta-analysis of the literature has revealed significant associations between chronic HCV infection, thyroid autoimmunity and hypothyroidism. Furthermore, a high prevalence of thyroid cancer has been reported in HCV-positive patients. Several clinicoepidemiological studies have demonstrated that chronic HCV infection could lead to the development of type 2 diabetes mellitus, possibly as a result of HCV-induced metabolic disturbances. Some researchers have postulated that a type 1 T-helper -cell mediated immune response underpins the association of chronic HCV infection with endocrine disease. Indeed, the available data suggest that a common immunological, type 1 T-helper cell pattern of cytokine expression and activation (via interferon-gamma) could provide the pathophysiological basis for this association. Nonetheless, additional studies will be necessary to elucidate fully all the mechanisms involved in HCV-related endocrine dysfunction.

Entities:  

Mesh:

Year:  2009        PMID: 19079271     DOI: 10.1038/ncpendmet1027

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN: 1745-8366


  60 in total

1.  Hepatitis C virus infection and human pancreatic beta-cell dysfunction.

Authors:  Matilde Masini; Daniela Campani; Ugo Boggi; Michele Menicagli; Nicola Funel; Maria Pollera; Roberto Lupi; Silvia Del Guerra; Marco Bugliani; Scilla Torri; Stefano Del Prato; Franco Mosca; Franco Filipponi; Piero Marchetti
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

2.  Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver.

Authors:  P L Shields; C M Morland; M Salmon; S Qin; S G Hubscher; D H Adams
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

3.  Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C.

Authors:  David Butera; Svetlana Marukian; Amy E Iwamaye; Edgardo Hembrador; Thomas J Chambers; Adrian M Di Bisceglie; Edgar D Charles; Andrew H Talal; Ira M Jacobson; Charles M Rice; Lynn B Dustin
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

Review 4.  IP-10 and type 1 diabetes: a question of time and location.

Authors:  Urs Christen; Matthias G von Herrath
Journal:  Autoimmunity       Date:  2004-06       Impact factor: 2.815

5.  Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.

Authors:  Thomas P Giordano; Louise Henderson; Ola Landgren; Elizabeth Y Chiao; Jennifer R Kramer; Hashem El-Serag; Eric A Engels
Journal:  JAMA       Date:  2007-05-09       Impact factor: 56.272

Review 6.  Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia.

Authors:  Alessandro Antonelli; Clodoveo Ferri; Silvia Martina Ferrari; Michele Colaci; Poupak Fallahi
Journal:  Autoimmun Rev       Date:  2008-08-15       Impact factor: 9.754

7.  Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection.

Authors:  Javier Bartolomé; Elena Rodríguez-Iñigo; Pedro Quadros; Sonia Vidal; Isabel Pascual-Miguelañez; José Antonio Rodríguez-Montes; Luis García-Sancho; Vicente Carreño
Journal:  J Med Virol       Date:  2008-09       Impact factor: 2.327

8.  Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans.

Authors:  I Okayasu; M Fujiwara; Y Hara; Y Tanaka; N R Rose
Journal:  Cancer       Date:  1995-12-01       Impact factor: 6.860

9.  Thyroid disorders in chronic hepatitis C.

Authors:  Alessandro Antonelli; Clodoveo Ferri; Alessandro Pampana; Poupak Fallahi; Claudia Nesti; Martina Pasquini; Santino Marchi; Ele Ferrannini
Journal:  Am J Med       Date:  2004-07-01       Impact factor: 4.965

10.  Gene expression profile of T-cell-specific chemokines in human hepatocyte-derived cells: evidence for a synergistic inducer effect of cytokines and hepatitis C virus proteins.

Authors:  A Apolinario; P L Majano; R Lorente; O Núñez; G Clemente; C García-Monzón
Journal:  J Viral Hepat       Date:  2005-01       Impact factor: 3.728

View more
  36 in total

1.  Review.

Authors:  Hans L Tillmann
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-06

2.  Chemokine antagonism in chronic hepatitis C virus infection.

Authors:  Edgar D Charles; Lynn B Dustin
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

3.  Hepatitis C: thyroid dysfunction in patients with hepatitis C on IFN-alpha therapy.

Authors:  Alessandro Antonelli; Clodoveo Ferri; Poupak Fallahi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-11       Impact factor: 46.802

Review 4.  Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer.

Authors:  Clodoveo Ferri; Marco Sebastiani; Dilia Giuggioli; Michele Colaci; Poupak Fallahi; Alessia Piluso; Alessandro Antonelli; Anna Linda Zignego
Journal:  World J Hepatol       Date:  2015-03-27

Review 5.  Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Dilia Giuggioli; Andrea Di Domenicantonio; Ilaria Ruffilli; Alda Corrado; Silvia Fabiani; Santino Marchi; Clodoveo Ferri; Ele Ferrannini; Poupak Fallahi
Journal:  World J Diabetes       Date:  2014-10-15

Review 6.  Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy.

Authors:  Diego García-Compeán; José Alberto González-González; Fernando Javier Lavalle-González; Emmanuel Irineo González-Moreno; Jesús Zacarías Villarreal-Pérez; Héctor J Maldonado-Garza
Journal:  Dig Dis Sci       Date:  2016-02       Impact factor: 3.199

7.  Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis.

Authors:  Takahisa Nakamura; Masato Furuhashi; Ping Li; Haiming Cao; Gurol Tuncman; Nahum Sonenberg; Cem Z Gorgun; Gökhan S Hotamisligil
Journal:  Cell       Date:  2010-02-05       Impact factor: 41.582

Review 8.  Endocrine disorders associated with hepatitis C virus chronic infection.

Authors:  Michele Colaci; Lorenzo Malatino; Alessandro Antonelli; Poupak Fallahi; Dilia Giuggioli; Clodoveo Ferri
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

Review 9.  The role of chemokines in acute and chronic hepatitis C infection.

Authors:  Stephen Fahey; Eugene Dempsey; Aideen Long
Journal:  Cell Mol Immunol       Date:  2013-08-19       Impact factor: 11.530

Review 10.  Cytokines and HCV-related autoimmune disorders.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Ilaria Ruffilli; Poupak Fallahi
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.